Literature DB >> 17698650

The CD4+ T-cell response to adenovirus is focused against conserved residues within the hexon protein.

David Onion1, Laura J Crompton, Donald W Milligan, Paul A H Moss, Steven P Lee, Vivien Mautner.   

Abstract

Adenovirus is a significant pathogen in immunocompromised patients and is widely utilized as a gene delivery vector, so a detailed understanding of the human immune response to adenovirus infection is critical. This study characterized the adenovirus-specific CD4(+) T-cell response of healthy donors by incubation with whole virus or with individual hexon and fiber proteins. Adenovirus-specific CD4(+) T cells averaged 0.26 % of the CD4(+) T-cell pool and were detectable in all donors. T cells recognizing the highly conserved hexon protein accounted for 0.09 %, whereas no response was observed against the fiber protein. A panel of hexon-specific CD4(+) T-cell clones was generated and shown to lyse targets infected with adenovirus from different serotypes and species. Three CD4 T-cell epitopes are described, which map to highly conserved regions of the hexon protein.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17698650     DOI: 10.1099/vir.0.82867-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  12 in total

1.  Characterization of human antiviral adaptive immune responses during hepatotropic virus infection in HLA-transgenic human immune system mice.

Authors:  Eva Billerbeck; Joshua A Horwitz; Rachael N Labitt; Bridget M Donovan; Kevin Vega; William C Budell; Gloria C Koo; Charles M Rice; Alexander Ploss
Journal:  J Immunol       Date:  2013-07-05       Impact factor: 5.422

2.  Combined CD8+ and CD4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection.

Authors:  Maarten L Zandvliet; J H Frederik Falkenburg; Ellis van Liempt; Louise A Veltrop-Duits; Arjan C Lankester; Jayant S Kalpoe; Michel G D Kester; Dirk M van der Steen; Maarten J van Tol; Roel Willemze; Henk-Jan Guchelaar; Marco W Schilham; Pauline Meij
Journal:  Haematologica       Date:  2010-06-18       Impact factor: 9.941

Review 3.  New insights on adenovirus as vaccine vectors.

Authors:  Marcio O Lasaro; Hildegund C J Ertl
Journal:  Mol Ther       Date:  2009-06-09       Impact factor: 11.454

4.  Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1.

Authors:  Adel Benlahrech; Julian Harris; Andrea Meiser; Timos Papagatsias; Julia Hornig; Peter Hayes; Andre Lieber; Takis Athanasopoulos; Veronique Bachy; Eszter Csomor; Rod Daniels; Kerry Fisher; Frances Gotch; Len Seymour; Karen Logan; Romina Barbagallo; Linda Klavinskis; George Dickson; Steven Patterson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-16       Impact factor: 11.205

5.  Tropism-modification strategies for targeted gene delivery using adenoviral vectors.

Authors:  Lynda Coughlan; Raul Alba; Alan L Parker; Angela C Bradshaw; Iain A McNeish; Stuart A Nicklin; Andrew H Baker
Journal:  Viruses       Date:  2010-10-13       Impact factor: 5.818

6.  Infection with host-range mutant adenovirus 5 suppresses innate immunity and induces systemic CD4+ T cell activation in rhesus macaques.

Authors:  Huma Qureshi; Meritxell Genescà; Linda Fritts; Michael B McChesney; Marjorie Robert-Guroff; Christopher J Miller
Journal:  PLoS One       Date:  2014-09-09       Impact factor: 3.240

Review 7.  Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic Applications.

Authors:  Hanni Uusi-Kerttula; Sarah Hulin-Curtis; James Davies; Alan L Parker
Journal:  Viruses       Date:  2015-11-24       Impact factor: 5.048

8.  Prion-like Domains in Eukaryotic Viruses.

Authors:  George Tetz; Victor Tetz
Journal:  Sci Rep       Date:  2018-06-12       Impact factor: 4.379

9.  Vaccination with recombinant adenovirus expressing peste des petits ruminants virus-F or -H proteins elicits T cell responses to epitopes that arises during PPRV infection.

Authors:  José Manuel Rojas; Miguel Avia; Elena Pascual; Noemí Sevilla; Verónica Martín
Journal:  Vet Res       Date:  2017-11-21       Impact factor: 3.683

10.  Optimising T cell (re)boosting strategies for adenoviral and modified vaccinia Ankara vaccine regimens in humans.

Authors:  Stefania Capone; Anthony Brown; Felicity Hartnell; Mariarosaria Del Sorbo; Cinzia Traboni; Ventzislav Vassilev; Stefano Colloca; Alfredo Nicosia; Riccardo Cortese; Antonella Folgori; Paul Klenerman; Eleanor Barnes; Leo Swadling
Journal:  NPJ Vaccines       Date:  2020-10-12       Impact factor: 9.399

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.